accountfrom sliding product prices. In the domestic market, Boston Scientific's current top-selling coated stent is called...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ABBOTT LABORATORIES
Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.
Abbott Laboratories is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
921 news
and
191 blog
items.
Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from
like-minded professionals.
News
Please add new articles to this topic
findings on May 19 * Abbott shares down 1 percent WASHINGTON, April 25 (Reuters) - A study of Abbott Laboratories' (ABT.
the death rates in studies of tofacitinib are similar to approved therapies like Humira and Simponi, made by Abbott...
as the most likely new Pfizer compound to generate $1 billion in annual sales by 2015. Shares in Abbott Laboratories,...
blockbuster cardiovascular drug in the making, which should attract Big Pharma attention. Pfizer(PFE), Merck(MRK),...
is an oral pill that Pfizer hopes can be an alternative to injectible and infused rheumatoid-arthritis drugs, including...
Pfizer Inc's experimental arthritis drug sent its shares down 3 percent, while lifting shares of rival drugmaker Abbott...
developing tofacitinib, an orally administered drug, as an alternative to such popular injected or infused...
pill intended as an alternative to current injectable and infused drugs. One such injectable and infused drug is Abbott...
commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, and Abbott...
1st-quarter profit falls 14% despite surge in sales Abbott Laboratories' first-quarter profit dipped 14 percent,...
selections. Motley Fool Options has recommended diagonal call positions on Microsoft and PepsiCo. The Fool owns shares...
(Crain?s) ? Despite a hefty 17% increase in first-quarter sales, Abbott Laboratories Inc.?s stock price remained stuck...
boosted through 2012, UBS said. iPhone sales continue to drive growth. Buy rating and new $495 price target.
Abbott Laboratories has reported stronger-than-expected quarterly sales, helped by growth of its Humira arthritis drug...
telecom giant reported its best-ever increase in total wireless subscribers for the first three months of the year...
most of its businesses, but its Cessna operation continued to struggle. Shares slumped 3% to $25.01 premarket.
Abbott Laboratories (ABT.N) reported slightly better-than-expected quarterly earnings on strong sales of branded and...
NEW YORK (TheStreet) -- Drug and medical device maker Abbott Laboratories(ABT) saw earnings drop 14% during the first...
Abbott Laboratories (ABT.N) reported slightly better-than-expected quarterly earnings on strong sales of branded and...
Drug and medical device maker Abbott Laboratories says its first-quarter profit fell 14 percent on restructuring and...
to Sell GM Stake ��� Tax Loss Carry Forward Dick Bove Cuts Goldman Rating Post Earnings Key Earnings Abbott...
NEW YORK (MarketWatch) -- Abbott Laboratories (NYSE:ABT
report results before the opening bell, as will railroad giant Union Pacific (UNP, Fortune 500), and healthcare...
Melsungen) Key players in the DES market Summary Introduction Relative positioning of the leading market participants...
Top Sources: Abbott Laboratories
- BusinessWeek
- MarketWatch
- Reuters
- Chicago Tribune
- thedeal.com
- chicagobusiness.com
- CNN Money
- TheStreet.com
- CNBC
- innovationexcellence.com
